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Xerostomia is a major radiation induced side effect in the treatment of head and neck (H&N) cancer. Oral lubricants 
provide short-acting symptomatic relief. Objective: To compare the efficacy of OralBalance© gel delivered by 
controlled-release via a novel intraoral device (IOD) versus an oral bolus of gel on the oral health-related quality of 
life (OHRQoL) of patients who had received radiotherapy for nasopharyngeal carcinoma. Methods: A randomized 
single-blind crossover design to compare efficacy between the two treatments. 22 disease-free participants were 
divided into two groups: one group first received treatment with gel alone, applied as required, whilst the other group 
first received gel “on demand” via an IOD. The device comprised a palatal plate and reservoir/ball-valve system 
attached to the teeth with clasps. Each treatment period lasted four weeks with an intervening four week washout 
period. The GOHAI, Xerostomia Inventory (XI), and a patient satisfaction questionnaire were self-completed at 
baseline (wk0) and wks 4, 8 and 12 and a patient preference measure at wk 12. Data were analysed using paired-t/ 
Wilcoxon signed ranks tests. Results: There was no statistical difference in mean GOHAI scores pre- and post-
treatment for gel alone (45.8[SD 7.1], 43.7[SD 7.5]; p>0.05) and for device + gel (44.4[SD 7.6], 45.8[SD 7.5]; 
p>0.05). There was a significant difference in the mean XI score pre- and post-treatment for gel alone (35.6[SD 6.0], 
33.4 [SD 7.2]; p=0.02) and no difference for IOD + gel (34.9[SD 6.7], 34.1[SD6.7]; p>0.05). There was no 
significant difference in overall patient satisfaction with either treatment (p>0.05). However, two thirds of participants 
preferred to use gel alone. Conclusion: Slow-release of gel via the IOD did not appear to improve OHRQoL most 
probably because of IOD-related discomfort during function, whereas gel alone reduced the severity of xerostomia 
symptoms and was the treatment of choice. Supported by CRCG-HKU.  
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